Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riess

Showing results (1351-1360 of 1,489) with videos related to

Pageof 149
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2015
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trialR U Trappe, S Choquet, D Dierickx, et al.
Clinical Lung Cancer|April 4, 2015
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platformDavid R Gandara, Philip C Mack, Carol Bult, et al.
Archives of Neurology|October 10, 2007
Asian origin for the worldwide-spread mutational event in Machado-Joseph diseaseSandra Martins, Francesc Calafell, Claudia Gaspar, et al.
Human Molecular Genetics|March 7, 2003
Transgenic rat model of Huntington's diseaseStephan von Hörsten, Ina Schmitt, Huu Phuc Nguyen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutationKarim Kouz, Christina Lissewski, Stephanie Spranger, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDJ W Riess, H A Yu, X Le, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Nature Communications|September 4, 2019
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Clinical Genetics|December 31, 2020
Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2Yuri A Zarate, Katherine A Bosanko, Mary Ann Thomas, et al.
Pageof 149

Showing results (1351-1360 of 1,489) with videos related to

Sort By:
Pageof 149
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2015
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trialR U Trappe, S Choquet, D Dierickx, et al.
Clinical Lung Cancer|April 4, 2015
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platformDavid R Gandara, Philip C Mack, Carol Bult, et al.
Archives of Neurology|October 10, 2007
Asian origin for the worldwide-spread mutational event in Machado-Joseph diseaseSandra Martins, Francesc Calafell, Claudia Gaspar, et al.
Human Molecular Genetics|March 7, 2003
Transgenic rat model of Huntington's diseaseStephan von Hörsten, Ina Schmitt, Huu Phuc Nguyen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutationKarim Kouz, Christina Lissewski, Stephanie Spranger, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDJ W Riess, H A Yu, X Le, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Nature Communications|September 4, 2019
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's diseaseParaskevi Krashia, Alberto Cordella, Annalisa Nobili, et al.
Clinical Genetics|December 31, 2020
Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2Yuri A Zarate, Katherine A Bosanko, Mary Ann Thomas, et al.
Pageof 149